News

Five Common Causes of Fatigue in Parkinson’s Disease 1

Five Common Causes of Fatigue in Parkinson’s Disease

Fatigue is a common symptom experienced by nearly 50% of individuals with Parkinson’s disease, and can be debilitating and persistent, often unrelieved by rest. While fatigue can be a subjective experience, it is important for clinicians to understand potential underlying causes in order to provide appropriate management. Here, we highlight five common causes of fatigue […]

Five Common Causes of Fatigue in Parkinson’s Disease Read More »

The effectiveness and safety of Veklury® (Remdesivir) have been reaffirmed in groups of patients who are at high risk

Gilead Sciences, Inc. (Nasdaq: GILD) has reported positive findings from several studies related to COVID-19, which will be presented at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID). One Phase 3 clinical trial showed that Veklury® (remdesivir) was well tolerated by patients with moderate to severe renal impairment. In addition, a retrospective

The effectiveness and safety of Veklury® (Remdesivir) have been reaffirmed in groups of patients who are at high risk Read More »

Vaccination against COVID-19 does not worsen cognitive impairment in patients with HIV

A recent study conducted by experts from the Johns Hopkins University School of Medicine has found that patients living with HIV may experience worsened cognitive function during the first four months after being infected with SARS-CoV-2. However, the study suggests that these differences in cognitive function are likely attributable to HIV rather than COVID-19. The

Vaccination against COVID-19 does not worsen cognitive impairment in patients with HIV Read More »

India’s Thriving Pharmaceutical Industry: R&D and Government Support

India is a major player in the global pharmaceutical sector, with the largest supply of non-patented medicines and providing 20% of the world’s generic drug exports. According to the “Indian Economic Survey 2021,” India’s pharmaceutical market was estimated at $42 billion in 2021, and it could triple over the next decade. India’s pharmaceutical industry is

India’s Thriving Pharmaceutical Industry: R&D and Government Support Read More »

Is it possible to determine the presence of uropathogens in urine in 40 minutes?

On March 21, the UK’s National Institute for Health and Clinical Excellence (NICE) released draft recommendations for the use of point-of-care testing to improve antimicrobial prescribing for urinary tract infections (UTIs). The potential benefits of rapid diagnostics have been highlighted, but further data on test accuracy is needed before they can be utilized in the

Is it possible to determine the presence of uropathogens in urine in 40 minutes? Read More »

Antidepressants as a New Player in Antibiotic Resistance?

Antimicrobial resistance is largely driven by the overuse and misuse of antibiotics. However, the impact of other drugs in this process is often overlooked. Recently, Australian scientists conducted a study published in the journal PNAS showing that certain antidepressants, such as sertraline and duloxetine, can induce resistance in E. coli to various antibiotics. This highlights

Antidepressants as a New Player in Antibiotic Resistance? Read More »

Pfizer’s ZAVZPRET™ nasal migraine spray is the first to be approved by the FDA

Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant) nasal spray for the acute treatment of migraine with or without aura in adults.   This is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray. ZAVZPRET has been proven effective, tolerable, and safe in two

Pfizer’s ZAVZPRET™ nasal migraine spray is the first to be approved by the FDA Read More »

Exit mobile version